SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Theravance - THRX
An SI Board Since October 2004
Posts SubjectMarks Bans Symbol
74 12 0 THRX
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
24.06 and .053 in mrsa with better dosing is really good. They must have been bummrkrw-8/22/2006
23Thanks rkrw, As for me, if I get MRSA I want Telavancin. :-) Even if it did fIRWIN JAMES FRANKEL-8/22/2006
22Very close but not statistically superior in treating mrsa. Seems the telavancinrkrw-8/22/2006
21If I read that right THRX established non-inferiority but failed (P's of .05IRWIN JAMES FRANKEL-8/22/2006
20Theravance Announces Positive Results in Phase 3 Telavancin Complicated Skin andIRWIN JAMES FRANKEL-8/22/2006
19Drug-proof bug found in illegal tattoo customers CDC finds clusters of antibiotirkrw-6/23/2006
18Novartis bids £305m for Neutec... Message 22519908 ...A second medicine, Aunigel bates-6/11/2006
17THRX mentioned prominently in Forbes cover story on drug-resistant infections: DewDiligence_on_SI-6/10/2006
16>>SOUTH SAN FRANCISCO, CA--(MARKET WIRE)--Dec 5, 2005 -- Theravance, Inc. tuck-12/5/2005
15Hopefully lights a fire under gsk.rkrw-4/22/2005
14Message 21223661 <i>April 13 /PRNewswire-FirstCall/ -- VECTURA Group plc (nigel bates-4/22/2005
13Thanks, and welcome back! Cheers, Tucktuck-4/20/2005
12It's worth noting that Pat Humphrey, the EVP for discovery, came from GW at hm-4/20/2005
11>>SOUTH SAN FRANCISCO, Calif., April 7 /PRNewswire-FirstCall/ -- Theravanctuck-4/8/2005
10>>SOUTH SAN FRANCISCO, Calif., March 28 /PRNewswire-FirstCall/ -- Theravantuck-3/28/2005
9Exercise maba option, pass on short acting sedative hypnotic. Press Release Sorkrw-3/21/2005
8[Telavancin MOA & Efficacy versus Vancomycin] >>Antimicrobial Agents tuck-3/2/2005
7I'm not so keen on micu's. Once per week dosing sounds good until you thrkrw-1/6/2005
6[Telavancin -- clinical and preclinical studies] First blush, seems more potenttuck-1/6/2005
5Tuck, Lockup expiration hasn't happened yet. But a few insiders participaterkrw-1/6/2005
4>>South San Francisco, CA, January 3, 2005 - Theravance, Inc. (NASDAQ: THRtuck-1/6/2005
3Looking in EDGAR to check insider/VC bailing in Wave II companies such as this. tuck-1/6/2005
2Digging through the S1: A play on long acting beta agonists.... GSK.Theravancrkrw-10/6/2004
1IPO Message 20602855michael_f_murphy-10/5/2004
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News